Regional Infusion-Radioembolization

Surgical Oncology Clinics of North America

Volumn 17, Issue 4, 2008, Pages 957-985

  Dubel, Gregory J ^a   Soares, Gregory M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALBUMIN TC 99M; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BEVACIZUMAB; BILIRUBIN; CARCINOEMBRYONIC ANTIGEN; FLOXURIDINE; FLUORODEOXYGLUCOSE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MICROSPHERE; OXALIPLATIN; STEROID; YTTRIUM 90; ZIRCONIUM;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CARCINOID; CHEMOEMBOLIZATION; CLINICAL TRIAL; DRUG APPROVAL; DRUG MEGADOSE; DUODENUM ULCER; FATIGUE; FEVER; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LYMPHOCYTOPENIA; MICROENCAPSULATION; NEUROENDOCRINE TUMOR; NEUTROPENIA; PANCREATITIS; PATIENT MONITORING; RADIATION DOSE; RADIOEMBOLIZATION; RADIOFREQUENCY ABLATION; RADIOISOTOPE DECAY; RADIOISOTOPE THERAPY; REVIEW; SIDE EFFECT; ULCER; UPPER GASTROINTESTINAL BLEEDING; VOMITING;

CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY; YTTRIUM RADIOISOTOPES;

EID: 49849091157     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2008.04.008     Document Type: Review

References (90)

1. Bosch F.X., Ribes J., Cleries R., et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9 2 (2005) 191-211
2. Llovet J.M. Treatment of hepatocellular carcinoma. Curr Treat Options Gastroenterol 7 6 (2004) 431-441
3. Llovet J.M. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40 3 (2005) 225-235
4. Llovet J., Ricci S., Mazzaferro V., et al. Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC). [meeting abstracts]. J Clin Oncol 25 18 suppl (2007) LBA1
5. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 1 (2007) 43-66
6. Sasson A.R., and Sigurdson E.R. Surgical treatment of liver metastases. Semin Oncol 29 2 (2002) 107-118
7. Colucci G., Gebbia V., Paoletti G., et al. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 23 22 (2005) 4866-4875
8. Gilbert J., Jeffrey I., Evans M., et al. Sites of recurrent tumour after curative colorectal surgery: implications for adjuvant therapy. Br J Surg 71 3 (1984) 203-205
9. Weiss L., Grundmann E., Torhorst J., et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150 3 (1986) 195-203
10. Bernier J., Hall E.J., and Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer 4 9 (2004) 737-747
11. Dawson L.A., McGinn C.J., Normolle D., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18 11 (2000) 2210-2218
12. Lawrence T.S., Robertson J.M., Anscher M.S., et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 5 (1995) 1237-1248
13. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 4 (1992) 781-788
14. Taremi M., Ringash J., and Dawson L.A. Upper abdominal malignancies: intensity-modulated radiation therapy. Front Radiat Ther Oncol 40 (2007) 272-288
15. Wulf J., Guckenberger M., Haedinger U., et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45 7 (2006) 838-847
16. Abbe R. Technical note. Arch Röntgenol 15 (1910) 74
17. Ariel I.M. Treatment of metastases to the liver with interstitial radioactive isotopes. Surg Gynecol Obstet 110 (1960) 739-745
18. Muller J.H., and Rossier P.H. A new method for the treatment of cancer of the lungs by means of artificial radioactivity. Acta radiol 35 5-6 (1951) 449-468
19. Kim Y.S., Lafave J.W., and Maclean L.D. The use of radiating microspheres in the treatment of experimental and human malignancy. Surgery 52 (1962) 220-231
20. Ariel I.M. Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (90Y radiating microspheres). Ann Surg 162 (1965) 267-278
21. Grady E.D., Sale W., Nicolson Jr. W.P., et al. Intra-arterial radioisotopes to treat cancer. Am Surg 26 (1960) 678-684
22. Grady E.D., Sale W.T., and Rollins L.C. Localization of radioactivity by intravascular injection of large radioactive particles. Ann Surg 157 (1963) 97-114
23. Blanchard R.J., Lafave J.W., Kim Y.S., et al. Treatment of patients with advanced cancer utilizing Y90 microspheres. Cancer 18 (1965) 375-380
24. Blanchard R.J., Morrow I.M., and Sutherland J.B. Treatment of liver tumors with yttrium-90 microspheres alone. Can Assoc Radiol J 40 4 (1989) 206-210
25. Ehrhardt G.J., and Day D.E. Therapeutic use of 90Y microspheres. Int J Rad Appl Instrum B 14 3 (1987) 233-242
26. Breedis C., and Young G. The blood supply of neoplasms in the liver. Am J Pathol 30 5 (1954) 969-977
27. Archer S.G., and Gray B.N. Vascularization of small liver metastases. Br J Surg 76 6 (1989) 545-548
28. Ackerman N.B., Lien W.M., Kondi E.S., et al. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery 66 6 (1969) 1067-1072
29. Sigurdson E.R., Ridge J.A., Kemeny N., et al. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 5 11 (1987) 1836-1840
30. Fox R.A., Klemp P.F., Egan G., et al. Dose distribution following selective internal radiation therapy. Int J Radiat Oncol Biol Phys 21 2 (1991) 463-467
31. Limited S.M. SIR-Spheres product monograph. Available at:. http://www.sirtex.com.au/p=77 Accessed November 21, 2007
32. Kennedy A.S., Nutting C., Coldwell D., et al. Pathologic response and microdosimetry of 90Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60 5 (2004) 1552-1563
33. Campbell A.M., Bailey I.H., and Burton M.A. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 45 4 (2000) 1023-1033
34. Burton M.A., Gray B.N., Self G.W., et al. Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II. Cancer Res 45 11 Part 1 (1985) 5390-5393
35. Burton M.A., Gray B.N., and Coletti A. Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinoma. Eur J Cancer Clin Oncol 24 8 (1988) 1373-1376
36. Gray B., Van Hazel G., Hope M., et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12 12 (2001) 1711-1720
37. Stubbs R.S., Cannan R.J., and Mitchell A.W. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 5 3 (2001) 294-302
38. Kennedy A., Nag S., Salem R., et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the Radioembolization Brachytherapy Oncology Consortium. Int J Radiat Oncol Biol Phys 68 1 (2007) 13-23
39. Koukourakis M.I. Tumour angiogenesis and response to radiotherapy. Anticancer Res 21 6B (2001) 4285-4300
40. Eric J.H. Radiation biology. Cancer 55 S9 (1985) 2051-2057
41. Shepherd F.A., Rotstein L.E., Houle S., et al. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 70 9 (1992) 2250-2254
42. TheraSphere Yttrium-90 microspheres [package insert]. Kanata (ON), Canada: MDS Nordion; 2007.
43. SIR-Spheres Yttrium-90 microspheres [package insert]. Sydney (Australia): Sirtex Medical; 2007.
44. Lim L., Gibbs P., Yip D., et al. A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. BMC Cancer 5 1 (2005) 132
45. Liu D.M., Salem R., Bui J.T., et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16 7 (2005) 911-935
46. Goin J., Dancey J., and Hermann G. Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: a dose-ranging study. World J Nucl Med 2 (2003) 216-225
47. Ho S., Lau W.Y., Leung T.W., et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 23 8 (1996) 947-952
48. Leung T.W., Lau W.-Y., Ho S.K., et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33 4 (1995) 919-924
49. Bester L., and Salem R. Reduction of arteriohepatovenous shunting by temporary balloon occlusion in patients undergoing radioembolization. J Vasc Interv Radiol 18 10 (2007) 1310-1314
50. Salem R., Lewandowski R., Roberts C., et al. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15 4 (2004) 335-345
51. Salem R., and Thurston K.G. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and methodologic considerations. J Vasc Interv Radiol 17 8 (2006) 1251-1278
52. Carr B.I. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 10 2 Suppl 1 (2004) S107-S110
53. Salem R., Lewandowski R.J., Atassi B., et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16 12 (2005) 1627-1639
54. Lewandowski R., Sato K., Atassi B., et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30 4 (2007) 571-592
55. Szyszko T., Al-Nahhas A., Tait P., et al. Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun 28 1 (2007) 21-24
56. Ariel I.M., and Pack G.T. Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy. Cancer 20 5 (1967) 793-804
57. Ariel I.M., and Padula G. Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes. J Surg Oncol 10 4 (1978) 327-336
58. Grady E.D. Intrahepatic arterial 90-yttrium resin spheres to treat liver cancer. Int J Nucl Med Biol 5 6 (1978) 253-254
59. Gray B.N., Burton M.A., Kelleher D.K., et al. Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. J Surg Oncol 42 3 (1989) 192-196
60. Gray B.N., Anderson J.E., Burton M.A., et al. Regression of liver metastases following treatment with yttrium-90 microspheres. Aust N Z J Surg 62 2 (1992) 105-110
61. Anderson J.H., Goldberg J.A., Bessent R.G., et al. Glass yttrium-90 microspheres for patients with colorectal liver metastases. Radiother Oncol 25 2 (1992) 137-139
62. Andrews J.C., Walker S.C., Ackermann R.J., et al. Hepatic radioembolization with Yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35 10 (1994) 1637-1644
63. Gray B., Van Hazel G., Buck M., et al. Treatment of colorectal liver metastases with SIR-spheres plus chemotherapy. GI Cancer 3 4 (2000) 249-257
64. Stubbs R.S., Cannan R.J., and Mitchell A.W. Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 48 38 (2001) 333-337
65. Stubbs R.S., O'Brien I., and Correia M.M. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients. ANZ J Surg 76 8 (2006) 696-703
66. Wong C.Y., Salem R., Raman S., et al. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Eur J Nucl Med Mol Imaging 29 6 (2002) 815-820
67. Herba M.J., and Thirlwell M.P. Radioembolization for hepatic metastases. Semin Oncol 29 2 (2002) 152-159
68. Lewandowski R.J., Thurston K.G., Goin J.E., et al. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol 16 12 (2005) 1641-1651
69. ® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88 2 (2004) 78-85
70. Murthy R., Xiong H., Nunez R., et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16 7 (2005) 937-945
71. Popperl G., Helmberger T., Munzing W., et al. Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors. Cancer Biother Radiopharm 20 2 (2005) 200-208
72. Kennedy A.S., Coldwell D., Nutting C., et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience. Int J Radiat Oncol Biol Physics 65 2 (2006) 412-425
73. Sharma R.A., Van Hazel G.A., Morgan B., et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25 9 (2007) 1099-1106
74. Houle S., Yip T.K., Shepherd F.A., et al. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology 172 3 (1989) 857-860
75. Yan Z.P., Lin G., Zhao H.Y., et al. An experimental study and clinical pilot trials on Yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer. Cancer 72 11 (1993) 3210-3215
76. Dancey J.E., Shepherd F.A., Paul K., et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 41 10 (2000) 1673-1681
77. Geschwind J.F., Salem R., Carr B.I., et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127 5 Suppl 1 (2004) S194-S205
78. Goin J.E., Salem R., Carr B.I., et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol 16 2 (2005) 195-203
79. Lau W.Y., Leung W.T., Ho S., et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 70 5 (1994) 994-999
80. Lau W.Y., Ho S., Leung T.W., et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40 3 (1998) 583-592
81. Lau W.Y., Ho S., Leung W.T., et al. What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres?. Hepatogastroenterology 48 38 (2001) 338-340
82. Sangro B., Bilbao J.I., Boan J., et al. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 66 3 (2006) 792-800
83. ®) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94 7 (2006) 572-586
84. Herba M.J., Illescas F.F., Thirlwell M.P., et al. Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology 169 2 (1988) 311-314
85. Lewandowski R.J., Atassi B.A., Wong C.O., et al. Use of Yttrium-90 microspheres for the treatment of liver neoplasia: longterm follow-up (2006), Cardiovascular and Interventional Society of Europe, Rome (Italy)
86. Coldwell D., Nutting C., and Kennedy A.K. Use of Yttrium-90 SirSpheres to treat metastatic unresectable neuroendocrine tumors to the liver (2005), World Congress of Gastrointestinal Cancer, Barcelona (Spain)
87. Kennedy A.S., McNeillie P., Overton C., et al. Fractionation, dose selection, and response of hepatic metastases of neuroendocrine tumors after Y90 microsphere nrachytherapy (2006), American Brachytherapy Society, Orlando (FL)
88. Bangash A.K., Atassi B., Kaklamani V., et al. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 18 5 (2007) 621-628
89. Coldwell D.M., Kennedy A.S., and Nutting C.W. Use of Yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 69 3 (2007) 800-804
90. Coldwell D. Treatment of nodular cholangiocarcinoma with yttrium-90 microspheres. Presented at World Congress of Gastrointestinal Cancer. Barcelona (Spain); June 29, 2006.